EUVIMEDExplore EUVIMED
ÜbersichtsarbeitOpen access

Navigating the role of protein lactylation in prostate cancer and its implications for immunotherapy

Dongzhang Li, Kaifeng Wang, Guantao Lou, Wangjian Li, Quan Ma, Yu'e Liu, Yongliang Chen

Journal of Cancer · 2025-06-12 · 16 (8) · 2706-2719

DOI: 10.7150/jca.114137 ↗

At a glance

Übersichtsarbeit in Journal of Cancer, published on 2025-06-12. Written by Dongzhang Li and 6 co-authors. Institution: Dept of Urology, Shaoxing Central Hospital, Shaoxing, Zhejiang, 312030, China. Cited 4 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Prostate cancer is an aggressive malignancy with high prevalence and significant mortality, characterized by its remarkable metabolic adaptability and immune complexity. Emerging evidence has highlighted the critical role of post-translational modifications (PTMs) in cancer biology, with protein lactylation gaining attention as a novel PTM with profound implications. Lactylation, derived from lactate, links the altered metabolic processes of tumor cells to diverse cellular functions, including epigenetic regulation and protein dynamics. It significantly influences tumor progression, immune evasion, and therapeutic resistance by modulating key immune cells within the tumor microenvironment. The immunosuppressive conditions created by lactate and lactylation favor tumor survival in prostate cancer. Thus, targeting lactylation offers innovative strategies for treating prostate cancer. By leveraging lactylation modulation, particularly in combination with immune checkpoint inhibitors, there is potential to enhance anti-tumor immune responses and improve treatment outcomes. This review explores the intersection of metabolic alterations and immune modulation, underscoring lactylation as a promising therapeutic avenue in prostate cancer.

Subjects

Author keywords

immune checkpointsimmunotherapylactylationprostate cancertumor microenvironment

Authors and institutions

  • Dept of Urology, Shaoxing Central Hospital, Shaoxing, Zhejiang, 312030, China.
  • Dept of Urology, The Central Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, 312030, China.
  • Boston Children's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.

Cite

APA

Li, D., Wang, K., Lou, G., Li, W., Ma, Q., Liu, Y., & Chen, Y. (2025). Navigating the role of protein lactylation in prostate cancer and its implications for immunotherapy. Journal of Cancer, 16(8), 2706-2719. https://doi.org/10.7150/jca.114137

Vancouver

Li D, Wang K, Lou G, Li W, Ma Q, Liu Y, et al. Navigating the role of protein lactylation in prostate cancer and its implications for immunotherapy. Journal of Cancer. 2025;16(8):2706-2719. doi:10.7150/jca.114137

BibTeX
@article{Li2025,
  author = {Li, Dongzhang and Wang, Kaifeng and Lou, Guantao and Li, Wangjian and Ma, Quan and Liu, Yu'e and Chen, Yongliang},
  title = {Navigating the role of protein lactylation in prostate cancer and its implications for immunotherapy},
  journal = {Journal of Cancer},
  year = {2025},
  volume = {16},
  number = {8},
  pages = {2706--2719},
  doi = {10.7150/jca.114137}
}
Start for free →